These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 15448217

  • 61. Somatic hypermutation of immunoglobulin heavy chain variable region genes in thymic marginal zone B-cell lymphoma of MALT type of a patient with Sjögren's syndrome.
    Kamimura K, Nakamura N, Ishibashi T, Maruyama Y, Abe M.
    Histopathology; 2002 Mar; 40(3):294-6. PubMed ID: 11895498
    [No Abstract] [Full Text] [Related]

  • 62.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 63.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 64.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 65.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 66. Rituximab as first line treatment for MALT lymphoma of extraocular muscles.
    Benetatos L, Alymara V, Asproudis I, Bourantas KL.
    Ann Hematol; 2006 Sep; 85(9):625-6. PubMed ID: 16691396
    [No Abstract] [Full Text] [Related]

  • 67. [MALT-lymphomas in Sjogren's disease].
    Vasil'ev VI, Probatova NA, Tupitsin NN, Varlamova EIu, Logvinenko OA, Rodionova EB, Kovrigina AM, Kokosadze NV, Panin MG, Gaĭduk IV, Gorbunova TV, Kondrat'eva TT, Sholokhova EN, Simonova MV, Safonova TN, Radenska-Lopovok SG.
    Ter Arkh; 2006 Sep; 78(1):45-52. PubMed ID: 16512445
    [Abstract] [Full Text] [Related]

  • 68. Successful treatment with rituximab in a patient with mental nerve neuropathy in primary Sjögren's syndrome.
    Sève P, Gachon E, Petiot P, Stankovic K, Charhon A, Broussolle C.
    Rheumatol Int; 2007 Dec; 28(2):175-7. PubMed ID: 17641898
    [Abstract] [Full Text] [Related]

  • 69. Response of factor V inhibitor to rituximab in a patient who received liver transplantation for primary biliary cirrhosis.
    Lian EC, Tzakis AG, Andrews D.
    Am J Hematol; 2004 Dec; 77(4):363-5. PubMed ID: 15551286
    [Abstract] [Full Text] [Related]

  • 70. CASE 3. Red eye in Sjogren's syndrome due to underlying mucosa-associated lymphoid tissue lymphoma.
    von Moos R, Ruhstaller T, Fretz C.
    J Clin Oncol; 2006 Feb 20; 24(6):1011-3. PubMed ID: 16484707
    [No Abstract] [Full Text] [Related]

  • 71. [Extranodal marginal zone lymphoma of the ocular adnexa].
    Møller A, Specht L, Toft PB, Sjø LD.
    Ugeskr Laeger; 2008 Nov 03; 170(45):3660-3. PubMed ID: 18986616
    [Abstract] [Full Text] [Related]

  • 72. Incidence of thromboembolic events in patients with primary Sjögren's syndrome.
    Haga HJ, Jacobsen EM, Peen E.
    Scand J Rheumatol; 2008 Nov 03; 37(2):127-9. PubMed ID: 18415770
    [Abstract] [Full Text] [Related]

  • 73.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 74.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 75. Concurrent Sjögren's syndrome in a patient with ulcerative colitis during infliximab therapy: a rare association.
    Qanneta R, Papo M, Fontova R.
    J Crohns Colitis; 2013 Sep 03; 7(8):e327-8. PubMed ID: 23380293
    [No Abstract] [Full Text] [Related]

  • 76. [Prognostic implications of mixed monoclonal cryoglobulinemia in Sjogren's disease].
    Vasil'ev VI, Probatova NA, Varlamova EIu, Tupitsin NN, Simonova MV, Safonova TN, Bozh'eva LA, Shornikova NS, Logvinenko OA, Belenin GIu.
    Ter Arkh; 2004 Sep 03; 76(8):61-8. PubMed ID: 15471400
    [Abstract] [Full Text] [Related]

  • 77. Epratuzumab (humanised anti-CD22 antibody) in primary Sjögren's syndrome: an open-label phase I/II study.
    Steinfeld SD, Tant L, Burmester GR, Teoh NK, Wegener WA, Goldenberg DM, Pradier O.
    Arthritis Res Ther; 2006 Sep 03; 8(4):R129. PubMed ID: 16859536
    [Abstract] [Full Text] [Related]

  • 78. Primary Sjogren's syndrome complicated by bilateral pleural effusion.
    Teshigawara K, Kakizaki S, Horiya M, Kikuchi Y, Hashida T, Tomizawa Y, Sohara N, Sato K, Takagi H, Matsuzaki S, Mori M.
    Respirology; 2008 Jan 03; 13(1):155-8. PubMed ID: 18197929
    [Abstract] [Full Text] [Related]

  • 79. Systemic vasculitis developing after hydroxychloroquine interruption in a patient with Sjögren's syndrome.
    Okan G, Karaaslan M, Büyükbabani N.
    Clin Exp Dermatol; 2010 Jun 03; 35(4):442-3. PubMed ID: 19886967
    [No Abstract] [Full Text] [Related]

  • 80. Systemic immunomodulatory therapy in severe dry eye secondary to inflammation.
    Cordero-Coma M, Anzaar F, Sobrin L, Foster CS.
    Ocul Immunol Inflamm; 2007 Jun 03; 15(2):99-104. PubMed ID: 17558834
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.